Ventyx Biosciences, Inc. - Common Stock (NQ:VTYX)

13.87 -0.01 (-0.07%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2026 Add to My Watchlist

Price and Volume

Volume	3,163,936
Open	13.86
Bid (Size)	13.81 (1,000)
Ask (Size)	13.86 (5,900)
Prev. Close	13.88
Today's Range	13.85 - 13.89
52wk Range	0.7830 - 25.00
Shares Outstanding	58,556,952
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights

Today 14:42 EST

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc.

Today 11:00 EST

From Brodsky & Smith LLC

Via GlobeNewswire

Performance

YTD	+65.1%	+65.1%
1 Month	+48.5%	+48.5%
3 Month	+268.9%	+268.9%
6 Month	+359.3%	+359.3%
1 Year	+566.8%	+566.8%

More News

Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? ↗

January 17, 2026

Via The Motley Fool

Halper Sadeh LLC Encourages ONTF, VTYX, SNCY Shareholders to Contact the Firm to Discuss Their Rights

January 17, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation

January 15, 2026

Via MarketMinute

Halper Sadeh LLC Encourages VTYX, PEN, CWAN Shareholders to Contact the Firm to Discuss Their Rights

January 15, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC Encourages VTYX, ONTF, FFIC, OCFC Shareholders to Contact the Firm to Discuss Their Rights

January 14, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns ↗

January 13, 2026

Via MarketBeat

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

January 13, 2026

From Pomerantz LLP

Via GlobeNewswire

Halper Sadeh LLC Encourages VTYX, ONTF, FFIC, OCFC Shareholders to Contact the Firm to Discuss Their Rights

January 13, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc. (Nasdaq - VTYX), Flushing Financial Corp. (Nasdaq - FFIC), FONAR Corporation (Nasdaq -

January 12, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences

January 09, 2026

Via MarketMinute

On Friday, there are stocks with unusual volume. Let's take a look. ↗

January 09, 2026

Via Chartmill

VTYX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Ventyx Biosciences, Inc. is Fair to Shareholders

January 08, 2026

From Halper Sadeh LLC

Via Business Wire

Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗

January 08, 2026

Via Stocktwits

Ventyx’s $1.2B Buyout By Eli Lilly Proves Timing Often Beats Conviction In Biotech Investing — A VC Explains ↗

January 07, 2026

Via Stocktwits

Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal ↗

January 07, 2026

Via Stocktwits

Wednesday's pre-market session: top gainers and losers ↗

January 07, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Tread Water Ahead Of ADP Data: Why NVDA, META, APLD, VTYX, ALMS Are On Traders' Radar Today ↗

January 07, 2026

Via Stocktwits

Tuesday's after hours session: top gainers and losers ↗

January 06, 2026

Via Chartmill

Ventyx Biosciences Stock Jumps On Reports Of Eli Lilly Buyout ↗

January 06, 2026

Via Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

Ventyx Provides Clinical and Corporate Updates

December 02, 2025

From Ventyx Biosciences, Inc.

Via GlobeNewswire

Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference

December 01, 2025

From Ventyx Biosciences, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Ventyx Biosciences, Inc. - Common Stock publicly traded?

Yes, Ventyx Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Ventyx Biosciences, Inc. - Common Stock trade on?

Ventyx Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Ventyx Biosciences, Inc. - Common Stock?

The ticker symbol for Ventyx Biosciences, Inc. - Common Stock is VTYX on the Nasdaq Stock Market

What is the current price of Ventyx Biosciences, Inc. - Common Stock?

The current price of Ventyx Biosciences, Inc. - Common Stock is 13.87

When was Ventyx Biosciences, Inc. - Common Stock last traded?

The last trade of Ventyx Biosciences, Inc. - Common Stock was at 01/21/26 04:00 PM ET

What is the market capitalization of Ventyx Biosciences, Inc. - Common Stock?

The market capitalization of Ventyx Biosciences, Inc. - Common Stock is 812.18M

How many shares of Ventyx Biosciences, Inc. - Common Stock are outstanding?

Ventyx Biosciences, Inc. - Common Stock has 812M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.